JSM Women's Health

Inclusive Healthcare Settings: Promoting Post-operative Follow-up in Transgender Voice Care through Awareness and Education

Research Article | Open Access | Volume 4 | Issue 1

  • 1. Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, USA
+ Show More - Show Less
Corresponding Authors
Zara Sragi, Department of Otolaryngology--Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1189, New York, NY, 10029, USA, Tel: 248-872-2156; Fax: 212-427-4088

Objectives: Gender-affirming laryngeal surgeries are becoming more common. Surgical outcomes for benign laryngeal disease are often affected by post-operative care. Documented barriers to medical care faced by transgender persons may affect their ability to participate in post-operative care visits and may affect their overall outcome. This study was initiated to compare the post-operative follow-up rates between patients who underwent gender-affirming laryngeal surgery and those who underwent voice surgery for non-neoplastic vocal fold lesions.

Methods: We conducted a retrospective chart review of patients who underwent laryngeal surgery for either gender-affirmation or non-neoplastic vocal fold lesions between January 2017 and June 2022. All post-operative visits were scheduled pre-operatively for both groups. The percentage of actual visits attended out of total visits scheduled was calculated. Standard statistical tests were performed to compare the groups.

Results: The study included 228 patients; 30 underwent surgery for non-neoplastic vocal fold lesions, and 198 underwent gender-affirming laryngeal surgeries. The follow-up rate for patients who underwent gender-affirming laryngeal surgeries was 69.9%, and 58.1% for those who underwent non-neoplastic vocal fold lesion surgeries (p= .026). This significance was observed only when polypectomies were included in the analysis, whereas the follow-up rates for cyst and granuloma removal were similar to transgender individuals who underwent gender-affirming surgery.

Conclusion: Despite known disparities and potential barriers to care, this study found that post-operative follow-up rates for transgender women were similar or slightly higher than those of cisgender patients who underwent removal of benign laryngeal disease. Future multi-centric studies are needed to evaluate the follow-up rates for other gender-affirming surgeries to identify potential disparities.


Gender-affirming, Transgender, Wendler glottoplasty, Post-operative follow-up


Sragi Z, Farrell B, Vasan V, Courey MS (2023) Inclusive Healthcare Settings: Promoting Post-operative Follow-up in Transgender Voice Care through Awareness and Education. JSM Women’s Health 4(1): 1013.


Gender-affirming surgery, also referred to as gender reassignment surgery, includes any surgical procedure designed to alleviate gender dysphoria, a condition where a person experiences distress and discomfort due to their gender identity being incongruent with their physical appearance[1]. For many individuals who identify as transgender, their voice can be a significant source of dysphoria, causing distress and discomfort when speaking or being addressed [2].Gender-affirming voice surgery in combination with voice therapy can alleviate this distress by modifying pitch, resonance, articulatory patterns, and inflection patterns (among other things) within words and phrases to better align voice and speech with the individual’s gender identity [3]. In addition to being transgender, many of these individuals belong to other minority communities and are subjected to significant healthcare disparities. There are several systemic and individual factors that contribute to health inequities within minority communities, including access to healthcare, socioeconomic factors, culture and language barriers, and discrimination. Transgender individuals also have limited access to gender-affirming care, stigma from healthcare providers, and higher rates of mental health issues [4,5]. These factors can hinder a patient’s ability to follow-up with providers.

Post-operative follow-up care is essential for optimal surgical outcomes and patient satisfaction [6]. During follow-up visits after voice surgery, clinicians typically address healing and voice rehabilitation. Research has shown that post-operative physical rehabilitation is beneficial for patients undergoing orthopedic procedures [7]. Similarly, in outpatient laryngeal surgery for benign disease, although not statistically proven, it is commonly thought that pre-operative and post-operative voice therapy can improve result [8,9]. Modifying the voice before surgery may enhance outcomes for transgender patients, with post-operative rehabilitation necessary for optimal results [9]. If transgender patients experience barriers to care, this may affect their ability to attend post-operative visits, and ultimately their overall outcome.

Therefore, we sought to compare the follow-up rates of transgender patients undergoing gender-affirming procedures with a control group of cisgender patients who also underwent laryngeal surgery. All patients had their three-month series of post-operative visits scheduled at the time their surgical procedure was scheduled. The purpose of these visits is to monitor healing and adjust the patients vocal use patterns which have been demonstrated to affect overall outcome. The primary outcome measure was the percentage of pre-scheduled postoperative follow-up visits attended within a three-month period. The secondary outcome measure was the comparison of the number of pre-operative visits, race, patient satisfaction, and age and follow-up rates in the transgender cohort.


This retrospective chart review study was conducted at a single center between January 2017 and June 2022. The patients were divided into two groups: cisgender patients who underwent laryngeal surgery for non-neoplastic vocal fold lesions, and transgender patients who underwent laryngeal surgery for gender-affirmation. The study was approved by the Mount Sinai Hospital System Institutional Review Board, and a waiver of informed consent was granted since patient data were deidentified. All procedures were performed by the senior author (MSC). Patient demographic data, surgical details, pre-operative and post-operative patient-reported outcome measures (PROMs), and follow-up visit information were extracted from medical charts for analysis. PROMs included the Transwomen Voice Questionnaire (TWVQ) for the gender affirming population, and the Voice Handicap Index (VHI-10) for the cisgender lesion population. Lower scores on the TWVQ and VHI-10 signify higher patient satisfaction.

After a gender-affirming endoscopic vocal fold shortening or non-neoplastic vocal fold lesion removal, the recommended follow-up periods are one week, four weeks, two months, and three months. For those who received only thyroid cartilage reduction or cyst removal, follow-up visits were scheduled at one week, six weeks, and three months post-operatively. The followup period examined in this study was three months after surger.

In post-hoc analysis, the cisgender patients who underwent surgery for non-neoplastic disease were subdivided into three groups: cysts, polyps, and granuloma.

The Shapiro-Wilk test was used to determine the distribution of the data. The non-parametric data was analyzed using the Mann-Whitney U Test and the Spearman. The Student’s T-test was used for parametric data. Analysis of variance (ANOVA) was used to assess differences in follow-up rates between ethnicities and locations. The significance level was set at p < 0.05.


A total of 228 patients who underwent outpatient laryngeal surgery between 2017 and 2022 were identified. Among them, 30 patients underwent surgery for non-neoplastic vocal fold lesions, including polyp (12), cyst (11), granuloma (6), or nodule (1) removal. The remaining 198 patients underwent gender-affirming laryngeal surgeries such as endoscopic vocal fold shortening and/or thyroid cartilage reduction. Patient demographic data are presented in Table 1 (Table 1a: Transgender cohort demographics, Table 1b: Cisgender cohort demographics).

Table 1: Patient Demographics

        All Transgender Endoscopic Vocal Fold Shortening TCR Endoscopic Vocal Fold Shortening and TCR  
Sample Size N 198 90 47 61  
Gender % Female 100% 100% 100% 100%  
Age Mean (SD) 34.7 38.1 28.8 34.3  
Ethnicity White, N (%) 83 (42%) 32 (36%) 27 (57%) 24 (39%)  
African American, N (%) 50 (25%) 28 (31%) 5 (11%) 17 (28%)  
Hispanic, N (%) 48 (24%) 23 (25%) 9 (19%) 16 (26%)  
Other, N (%) 17 (9%) 7 (8%) 6 (13%) 4 (7%)  
Location NYC, N (%) 147 (74%) 67 (74%) 33 (70%) 47 (77%)  
NY State, N (%) 22 (11%) 11 (12%) 7 (15%) 4 (7%)  
Neighboring States (NJ and CT), N (%) 14 (7%) 5 (6%) 4 (8%) 5 (8%)  
Out of State, N (%) 15 (8%) 7 (8%) 3 (7%) 5 (8%)  
B)    Cisgender cohort          
        All Cisgender Polyp Cyst Granuloma Nodule
Sample Size N 30 12 11 6 1
Gender % Female 46.70% 33.30% 54.50% 50% 100%
Age Mean (SD) 58.7 54.6 64.8 54.3 67
Ethnicity White, N (%) 17 (57%) 6 (50%) 7 (64%) 3 (50%) 1 (100%)
African American, N (%) 6 (20%) 4 (33%) 2 (18%) 0 0
Hispanic, N (%) 4 (13%) 2 (17%) 1 (9%) 1 (17%) 0
Other, N (%) 3 (10%) 0 1 (9%) 2 (33%) 0
Location NYC, N (%) 21 (70%) 10 (84%) 7 (64%) 3 (50%) 1 (100%)
NY State, N (%) 4 (13%) 1 (8%) 2 (18%) 1 (17%) 0
Neighboring States (NJ and CT), N (%) 5 (17%) 1 (8%) 2 (18%) 2 (33%) 0
  Out of State, N (%) 0 0 0 0 0

Abbreviations: TCR- Thyroid Cartilage Reduction, NYC- New York City; NJ- New Jersey; CT- Connecticut

Only one case of nodule removal was identified, which was included in the general analysis but not in individual analysis by surgical type.

The follow-up rate for all patients who underwent any gender affirming surgery was 69.9%, which was statistically higher than the follow-up rate of 58.1% for all patients who underwent nonneoplastic vocal fold lesion surgeries (p < .05).

The follow-up rate among transgender patients was not statistically different between those who received endoscopic vocal fold shortening, TCR, or both surgeries simultaneously.

Cisgender patients who underwent polyp removal had a statistically significant worse follow-up rate than other cisgender patients who underwent either cyst or granuloma removal (45.8% vs 69.7% and 66.7%, p < .05). The follow-up rate of cisgender patients after polypectomy was also worse than transgender individuals who underwent endoscopic vocal fold shortening (45.8% vs 71.1%, p < .05). Follow-up data is reported in Table 2 (Table 2a: Follow-up data in the Transgender cohort, Table 2b: Follow-up data in the Cisgender cohort).

Table 2: Follow-up visits

      All Transgender Endoscopic Vocal Fold Shortening TCR Endoscopic Vocal Fold Shortening and TCR  
Preoperative TWVQ 95.4/120 96.9/120 N/A 93.2/120  
Postoperative TWVQ  50.1/120 50.2/120 N/A 50.0/120  
# Pre-op Visits 3.4 3.5 N/A 3.3  
# Post-op Visits N/A 2.8 1.9 2.9  
Follow-up Rate 69.90% 71.10% 63.80% 72.90%  
B)    Follow-up visits and rates in the Cisgender population      
      All Cisgender Polyp Cyst Granuloma Nodule
Preoperative VHI-10 17.2 21.1 10.3 22.7 18
Postoperative VHI-10 6.3 7.4 2.2 7 28
# Pre-op Visits N/A N/A N/A N/A N/A
# Post-op Visits N/A 1.8 2 2.7 1
Follow-up Rate 58.10% 45.80% 69.70% 66.70% 25.00%

Abbreviations: TWVQ- Transwomen voice questionnaire; VHI-10 – Voice handicap index

Univariate analysis of patient demographics showed that race/ethnicity did not significantly affect the follow-up rates across both transgender and cisgender cohorts. The evaluation of follow-up rates of men and women in the cisgender cohort was comparable and not statistically significant. Analysis of followup trends over time showed that although there was a decrease in follow-up rates immediately after the COVID-19 pandemic in 2020 (across all surgeries), it was not statistically significant within both transgender and cisgender cohorts. Table 3 shows the univariate analysis, and Figure 1 shows the trend of follow-up rates over the years.

Table 3: Univariate Follow-up Rate Analysis

        All Transgender All Cisgender
Gender Female 69.90% 53.00%
  Male N/A 62.50%
Ethnicity White, (%) 71.80% 57%
African American, (%) 63.70% 20%
Hispanic, (%) 70.50% 13%
Other, (%) 77.90% 10%
Location NYC, (%) 69.70% 70%
NY State, (%) 11% 13%
Neighboring States (NJ and CT), (%) 7% 17%
Out of State, (%) 8% 0%

The study found that the average number of pre-surgical voice therapy visits before an endoscopic vocal fold shortening procedure was 3.4 (± 2.5). There was a weak positive correlation (r = .24) between the number of pre-surgical speech therapy visits and the follow-up rate in the transgender community.

Patient-reported outcomes were evaluated using the TWVQ questionnaire in the transgender population, and the VHI-10 questionnaire in the cisgender population. Both questionnaires showed improvements in scores from pre-operative to postoperative assessments, but there was no significant correlation between the questionnaire scores and follow-up rates.

Additionally, a correlation analysis was performed between the TWVQ scores and the number of pre-surgical speech therapy visits, but only a weak negative correlation was found in the post-operative TWVQ scores (r = .22). Table 2 provides more information on the patient-reported outcomes and the number of voice therapy visits.


Post-operative care is considered an essential component of patient outcome by many surgeons and most laryngologists. Specifically, during the post-operative visits after laryngeal surgery, the patients’ behavioral methods of voice production are assessed and modified as possible to influence healing and outcome. Therefore, if barriers to this care exist, efforts need to be developed to reduce these barriers. This study found that as a group, despite perceived barriers, transgender patients that underwent endoscopic vocal fold shortening and/or thyroid cartilage reduction had significantly higher follow-up rates than cisgender patients as a whole who underwent surgery for benign laryngeal disease. When cisgender patients were divided into groups based on their conditions, the polyp cohort had significantly lower follow-up rates than the cyst and granuloma groups, and follow-up rates for the remainder of the cisgender cohort equalized with that of the transgender cohort. Cisgender patients undergoing surgery for cysts or granulomas are presumed to have more diverse etiologies than those undergoing surgery for phono-traumatically induced polyps [10-12]. Cysts tend to be located deeper in the vocal fold tissue, which may require more extensive surgical work and resulted in stronger encouragement for patients to attend post-operative visits for rehabilitation. As a result, this condition is now being perceived as “more complex” and treated more similarly to patients undergoing gender-affirming surgery.

In contrast to a previous study showing that African-American patients had a higher likelihood of being lost to follow-up, this study found no significant differences in short-term follow-up rates by race for laryngeal surgery.13 The accessibility of genderaffirming surgery is influenced by insurance reimbursement rates, which can impact the care patients receive and their followup [14]. Transgender patients in our clinic had better followup rates, which might have been due to established insurance coverage or self-payment arrangements before their scheduled procedure.

In a study by Pattanasin et al. which looked at factors affecting loss to follow-up in men who have sex with men, they uncovered factors such as young age, education level, and distance to the provider being correlated with less follow-up [15]. This relationship was weakly expressed in the transgender cohort of this study. The cisgender patient cohort was significantly older, yet they had worse follow-up rates.

Previous work by Brown et al. showed that the combination of voice therapy and endoscopic vocal fold shortening produced the best voice outcomes, seen with a higher score on patientreported outcome measures [16]. Therefore, it was important to evaluate whether voice therapy visits prior to surgery could predict follow-up rates. This study revealed weak correlations between the number of pre-surgical voice therapy sessions and follow-up rates (r = .24). This could not be assessed in the cisgender cohort since many patients were not recommended to partake in voice therapy sessions pre-operatively, due to patient and/or provider preferences.

Research has demonstrated that post-operative rehabilitation for patients undergoing all types of surgery significantly impacts patient-reported outcomes [7,8,17]. Patients who participate in rehabilitation programs tend to have better PROMs than those who do not. For example, studies have shown that patients who participate in rehabilitation after total knee replacement surgery have better pain control, functional outcomes, and quality of life compared to those who do not [9]. Similarly, patients who participate in post-operative pulmonary rehabilitation after lung surgery have improved lung function, exercise capacity, and quality of life [17]. Our study showed that pre-operative voice rehabilitation was weakly correlated with improvements in patient-reported outcomes (r = -.22), while post-operative voice rehabilitation was not. This suggests that increased preoperative voice therapy visits were mildly associated with higher patient satisfaction, as indicated by lower TWVQ scores.

One limitation of this study was sample size variability. The transgender cohort had significantly more surgical patients compared with the cisgender cohort, which was likely due to previous correlations found between need for surgery and type of lesion [18]. Additionally, the cisgender population had different post-operative follow-up and pre-surgical voice therapy visit suggestions, making it challenging to compare these factors between the two populations.


Our clinic observed that despite potential barriers to care, post-operative follow-up rates for transgender women were higher than those for cisgender patients undergoing surgical removal of benign laryngeal disease. However, when the cisgender group was divided into different disease categories, this difference was only persistent for those patients’ undergoing removal of laryngeal polyps. The reason for this difference is not known but presumed to be perceived insignificance of the “polyp” diagnosis. In our setting, follow-up visit rate were not significantly influenced by factors such as race/ethnicity, age, or number of pre-operative visits. Future multi-centric studies are necessary to assess the follow-up rates for other genderaffirming surgeries to identify potential disparities.


1. Bizic MR, Jeftovic M, Pusica S, Stojanovic B, Duisin D, Vujovic S, et al. Gender Dysphoria: Bioethical Aspects of Medical Treatment. Biomed Res Int. 2018; 2018.

2. Gray ML, Courey MS. Transgender Voice and Communication. Otolaryngol Clin North Am. 2019; 52: 713-722.

3. Nolan IT, Morrison SD, Arowojolu O, Crowe CS, Massie JP, Adler RK, et al. The Role of Voice Therapy and Phonosurgery in Transgender Vocal Feminization. J Craniofac Surg. 2019; 30: 1368-1375.

4. Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, et al. Global health burden and needs of transgender populations: a review. Lancet. 2016; 388: 412-436.

5. James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M, et al. The Report of the 2015 U.S. Transgender Survey. National Center for Transgender Equality. 2016.

6. Abeln B, Love R. Considerations for the Care of Transgender Individuals. Nurs Clin North Am. 2019; 54: 551-559.

7. Fortier L, Rockov Z, Chen A, Rajaee S, Eli A Swanson, Thomas P Schmalzried, et al. Activity Recommendations After Total Hip and Total Knee Arthroplasty. J Bone Joint Surg Am. 2021; 103: 446-455.

8. Tibbetts KM, Dominguez LM, Simpson CB. Impact of Perioperative Voice Therapy on Outcomes in the Surgical Management of Vocal Fold Cysts. J Voice. 2018; 32: 347-351.

9. Tang SS, Thibeault SL. Timing of Voice Therapy: A Primary Investigation of Voice Outcomes for Surgical Benign Vocal Fold Lesion Patients. J Voice. 2017; 31: 129.e1-129.e7.

10.Vasconcelos D, Gomes AOC, Araújo CMT. Vocal Fold Polyps: Literature Review. Int Arch Otorhinolaryngol. 2019; 23: 116-124.

11.Sadoughi B, Rickert SM, Sulica L. Granulomas of the membranous vocal fold after intubation and other airway instrumentation. Laryngoscope. 2019; 129: 441-447.

12.Martins RH, Santana MF, Tavares EL. Vocal cysts: clinical, endoscopic, and surgical aspects. J Voice. 2011; 25: 107-110.

13.Psaty BM, Cheadle A, Koepsell TD, Diehr P, Wickizer T, Curry S, et al. Race- and ethnicity-specific characteristics of participants lost to follow-up in a telephone cohort. Am J Epidemiol. 1994; 140: 161-171.

14.Baker W, Rivlin M, Sodha S, Nakashian M, Katt B, Fletcher Det al. Variability in Medicaid Reimbursement in Hand Surgery May Lead to Inequality in Access to Patient Care. Hand (N Y). 2022; 17: 983-987.

15.Pattanasin S, Wimonsate W, Chonwattana W, Tongtoyai J, Chaikummao S, Sriporn A, et al. Loss to follow-up and bias assessment among a cohort of Thai men who have sex with men in Bangkok, Thailand. Int J STD AIDS. 2016; 27: 196-206.

16.Brown SK, Chang J, Hu S, Sivakumar G, Sataluri M, Goldberg L, et al. Addition of Wendler Glottoplasty to Voice Therapy Improves Trans Female Voice Outcomes. Laryngoscope. 2021; 131: 1588-1593.

17.Jones LW, Eves ND, Peterson BL, Garst J, Crawford J, West MJ, et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008; 113: 3430-3439.

18.Naunheim MR, Carroll TL. Benign vocal fold lesions: update on nomenclature, cause, diagnosis, and treatment. Curr Opin Otolaryngol Head Neck Surg. 2017; 25: 453-458.

Sragi Z, Farrell B, Vasan V, Courey MS (2023) Inclusive Healthcare Settings: Promoting Post-operative Follow-up in Transgender Voice Care through Awareness and Education. JSM Women’s Health 4(1): 1013.

Received : 20 Jun 2023
Accepted : 31 Jul 2023
Published : 31 Jul 2023
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X